Diphencyprone
- Generic Name
- Diphencyprone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H10O
- CAS Number
- 886-38-4
- Unique Ingredient Identifier
- I7G14NW5EC
- Background
Diphencyprone has been used in trials studying the treatment and basic science of Melanoma, Ultraviolet Rays, Immunosuppression, Neoplasm Metastasis, and Hypersensitivity, Delayed, among others.
- Associated Conditions
- Alopecia Areata (AA), Wart Viral
- Associated Therapies
- -
Effect of RANKL Inhibition on UV-induced Immunosuppression
- First Posted Date
- 2013-11-07
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT01978483
- Locations
- 🇨🇦
Innovaderm Research Inc., Montreal, Quebec, Canada
Analysis of Diphenylcyclopropenone (DPCP) in Normals
- First Posted Date
- 2011-10-17
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 30
- Registration Number
- NCT01452594
- Locations
- 🇺🇸
The Rockefeller University, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath